T-002

Supelco

Trinitroglycerin solution

1000 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Empirical Formula (Hill Notation):
C3H5N3O9
CAS Number:
Molecular Weight:
227.09
MDL number:
PubChem Substance ID:
NACRES:
NA.24

Quality Level

grade

certified reference material

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1000 μg/mL in acetonitrile

Featured Industry

Pharmaceutical (small molecule)

format

single component solution

storage temp.

−20°C

SMILES string

O=[N+]([O-])OCC(CO[N+]([O-])=O)O[N+]([O-])=O

InChI

1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2

InChI key

SNIOPGDIGTZGOP-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

Trinitroglycerin, also commonly known as nitroglycerin, is a pharmaceutical vasodilator used to treat heart conditions such as angina and chronic heart failure. This explosive compound is also an ingredient in dynamite and gunpowder. This Certified Spiking Solution® is suitable for use in chromatography or mass spectrometry-based applications in pharmaceutical research or clinical toxicology.

Legal Information

CERILLIANT is a registered trademark of Cerilliant Corporation
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation

Pictograms

FlameSkull and crossbones

Signal Word

Danger

RIDADR

UN 1648 3 / PGII

WGK Germany

WGK 2

Flash Point(F)

35.6 °F - closed cup

Flash Point(C)

2 °C - closed cup

Certificate of Analysis

Certificate of Origin

Hosein Kimiaei Asadi et al.
Acta cirurgica brasileira, 28(1), 19-25 (2013-01-23)
To evaluate the effect of nitroglycerine (NTG) on sensory and motor block onset and recovery time as well as the quality of tourniquet pain relief, when added to lidocaine (LID) for intravenous regional anesthesia in elective forearm and hand surgery....
Kate Kleydman et al.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 38(12), 1889-1897 (2012-12-05)
Skin necrosis after soft tissue augmentation with dermal fillers is a rare but potentially severe complication. Nitroglycerin paste may be an important treatment option for dermal and epidermal ischemia in cosmetic surgery. To summarize the knowledge about nitroglycerin paste in...
Guillaume Ruel et al.
Nutrition research (New York, N.Y.), 33(1), 41-49 (2013-01-29)
The stiffening of arteries is a key step in atherogenesis leading to cardiovascular disease. It has been suggested that dietary polyphenols may be cardioprotective through possible favorable effects on oxidative stress and vascular function. The present study was undertaken in...
Mirco Govoni et al.
The Journal of pharmacology and experimental therapeutics, 346(1), 96-104 (2013-04-19)
Liver first-pass metabolism differs considerably among organic nitrates, but little information exists on the mechanism of denitration of these compounds in hepatic tissue. The metabolism of nitrooxybutyl-esters of flurbiprofen and ferulic-acid, a class of organic nitrates with potential therapeutic implication...
Tatsuya Maruhashi et al.
Arteriosclerosis, thrombosis, and vascular biology, 33(6), 1401-1408 (2013-03-23)
Nitroglycerine-induced vasodilation has been used as a control test for flow-mediated vasodilation (FMD) to differentiate endothelium-dependent from endothelium-independent response when evaluating endothelial function in humans. Recently, nitroglycerine-induced vasodilation has also been reported to be impaired in patients with atherosclerosis. The...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.